Go Pro

English Capital Management LLC Trims Stock Holdings in Cigna Group $CI

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • English Capital Management cut its Cigna position by 17.8% in the second quarter, selling 3,922 shares and retaining 18,096 shares worth approximately $5.4 million. Institutional investors collectively own 86.99% of Cigna’s stock.
  • Cigna reported quarterly EPS of $7.78, exceeding analyst expectations of $7.60, while revenue rose 6.7% year over year to $70.04 billion. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $339.45.
  • Cigna declared a quarterly dividend of $1.56 per share, equivalent to $6.24 annually and a 2.2% yield; the dividend is payable September 23 to shareholders of record as of September 8.
  • Interested in Cigna Group? Here are five stocks we like better.

English Capital Management LLC reduced its position in Cigna Group (NYSE:CI - Free Report) by 17.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,096 shares of the health services provider's stock after selling 3,922 shares during the quarter. Cigna Group comprises approximately 2.4% of English Capital Management LLC's portfolio, making the stock its 19th biggest position. English Capital Management LLC's holdings in Cigna Group were worth $5,394,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CI. Assetmark Inc. grew its holdings in shares of Cigna Group by 10.0% during the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider's stock worth $17,515,000 after buying an additional 5,963 shares during the last quarter. Victory Capital Management Inc. raised its stake in Cigna Group by 41.1% during the 4th quarter. Victory Capital Management Inc. now owns 1,348,713 shares of the health services provider's stock valued at $371,206,000 after acquiring an additional 392,978 shares during the last quarter. WASHINGTON TRUST Co lifted its position in Cigna Group by 297.0% during the 4th quarter. WASHINGTON TRUST Co now owns 5,296 shares of the health services provider's stock worth $1,458,000 after acquiring an additional 3,962 shares during the period. Handelsbanken Fonder AB grew its stake in shares of Cigna Group by 12.1% in the 2nd quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider's stock valued at $22,833,000 after purchasing an additional 8,960 shares during the last quarter. Finally, CWM LLC grew its stake in shares of Cigna Group by 12.7% in the 4th quarter. CWM LLC now owns 84,803 shares of the health services provider's stock valued at $23,340,000 after purchasing an additional 9,566 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Analyst Upgrades and Downgrades

CI has been the subject of several analyst reports. Royal Bank Of Canada upped their price target on Cigna Group from $333.00 to $337.00 and gave the stock an "outperform" rating in a research note on Friday, May 1st. Wall Street Zen lowered shares of Cigna Group from a "buy" rating to a "hold" rating in a research report on Saturday, August 1st. Sanford C. Bernstein boosted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the company an "outperform" rating in a research note on Thursday, July 9th. Piper Sandler cut their price objective on shares of Cigna Group from $370.00 to $346.00 and set an "overweight" rating for the company in a research report on Wednesday, June 3rd. Finally, Cantor Fitzgerald raised their target price on shares of Cigna Group from $325.00 to $340.00 and gave the stock an "overweight" rating in a research note on Friday, May 1st. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, Cigna Group has an average rating of "Moderate Buy" and a consensus price target of $339.45.

Get Our Latest Analysis on Cigna Group

Cigna Group Trading Up 1.5%

NYSE:CI opened at $282.24 on Friday. The stock has a fifty day moving average price of $286.02 and a two-hundred day moving average price of $281.28. The stock has a market capitalization of $74.58 billion, a price-to-earnings ratio of 11.68, a PEG ratio of 0.96 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period in the previous year, the firm earned $7.20 EPS. The business's revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group's payout ratio is currently 25.82%.

Insider Activity

In other news, CAO Jamie G. Kates sold 899 shares of the business's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the company's stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company's stock.

Cigna Group Profile

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines